SHP2 Regulation of the Plasticity of Bone Marrow Osterix+ Stroma

SHP2 对骨髓 Osterix 基质可塑性的调节

• 批准号: 10701128
• 负责人: Wentian Yang
• 金额: $ 10万
• 依托单位: RHODE ISLAND HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-22 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10701128
• 关键词: Adipocytes; Adult; Affect; Age; B-Lymphocytes; Biology; Blood; Blood Cell Count; Blood Cells; Blood Circulation; Blood Vessels; Bone Marrow; Bone marrow failure; CD19 gene; CD34 gene; Cell Lineage; Cell Survival; Cells; Cellular biology; Characteristics; Common Lymphoid Progenitor; Data; Development; Embryo; Endothelium; Erythrocytes; Foundations; Frequencies; Genetic; Goals; Health; Hematological Disease; Hematopoiesis; Hematopoietic; Hematopoietic System; Hematopoietic stem cells; Homeostasis; Knowledge; Lymphocyte; Lymphoid; Lymphopoiesis; Megakaryocytes; Mesenchymal; Mesenchymal Differentiation; Modality; Molecular; Mus; Myelogenous; Myeloid Cells; Nature; Neonatal; Osteoblasts; Osteogenesis; Outcome Study; PTPN11 gene; PTPRC gene; Pericytes; Perinatal; Phenotype; Population; PubMed; Regulation; Reporter; Reporting; Role; SLAM family receptor; Skeletal Development; Sorting - Cell Movement; Stromal Cells; T-Lymphocyte; Testing; Text; Time; Tissues; United States National Library of Medicine; Work; Zinc Fingers; bone; cohort; granulocyte; hematopoietic differentiation; hematopoietic stem cell differentiation; innovation; leukemia; novel; novel marker; novel therapeutics; osteoblast differentiation; osteogenic; peripheral blood; postnatal; progenitor; promoter; skeletal; stem; stem cell survival; stem cells; transcription factor; tumor; tumorigenic; virtual

(PLEASE KEEP IN WORD, DO NOT PDF) This section must be no longer than 30 lines of text. It has been recently reported that the promoter of the master osteogenic transcription factor, OSTERIX, is active perinatally in hematopoietic cells, and that GFP+ blood cells circulate at low frequency in Tg(Osx-GFP:Cre) reporter mice. However, nothing is currently known about the significance of the hematopoietic cell-specific OSTERIX expression, and whether OSTERIX depletion might impact hematopoiesis. The work outlined in this proposal builds on the novel findings that Osx-GFP marks some BM and peripheral blood cells, and the number of these GFP+ blood cells decreases and disappears during development and maturation. Since OSTERIX expression and function in the hematopoietic system remain largely unknown, these findings together stimulate the hypothesis that OSTERIX is temporarily expressed in hematopoietic stem cells (HSCs) and that it is required for their survival, and/or lineage commitment and hematopoietic homeostasis. To test this novel hypothesis, we propose two specific Aims. In Aim 1, we will determine the dynamics of OSTERIX expression by quantifying GFP+ blood cells in embryonic, postnatal, and adult Tg(Osx-GFP:Cre) mice using FACS analysis. In Aim 2, we will determine the impact of OSTERIX depletion in HSCs on cell survival and multilineage differentiation using Tg(Mx1-Cre;Osxfx/fx) upon p(I)(C) induction. This innovative study will result in the first-ever description of OSTERIX’s regulatory role in the hematopoietic system and provide foundational information on the effect of OSTERIX dysregulation in blood. Successful completion of the work proposed will have a significant impact on our understanding of the hematopoietic regulation by OSTERIX and advance our knowledge about OSTERIX in the extraskeletal tissues.

(请保留在Word中，请勿使用PDF)此部分不得超过30行文本。 最近有报道称，主要成骨转录因子OSTERIX的启动子在围生期的造血细胞中是活跃的，在TG(OSX-GFP：CRE)报告小鼠中GFP+血细胞以低频率循环。然而，目前还不知道造血细胞特异性OSTERIX表达的意义，以及OSTERIX耗竭是否会影响造血。这项提案中概述的工作建立在一项新发现的基础上，即OSX-GFP标记一些骨髓和外周血细胞，这些GFP+血细胞的数量在发育和成熟过程中减少和消失。由于OSTERIX在造血系统中的表达和功能在很大程度上仍不清楚，这些发现共同支持了一种假设，即OSTERIX在造血干细胞(HSCs)中暂时表达，是它们生存和/或血统承诺和造血稳态所必需的。为了检验这一新的假设，我们提出了两个具体目标。在目标1中，我们将通过FACS分析对胚胎、出生后和成年TG(OSX-GFP：CRE)小鼠的GFP+血细胞进行定量，以确定OSTERIX的表达动态。在目标2中，我们将使用TG(Mx1-Cre；Osxfx/Fx)在p(I)(C)诱导下确定OSTERIX缺失对HSCs存活和多系分化的影响。这项创新性的研究将首次描述OSTERIX在造血系统中的调节作用，并为OSTERIX在血液中的调节失调的影响提供基础信息。这项工作的成功完成将对我们理解OSTERIX的造血调节作用产生重大影响，并促进我们对OSTERIX在骨外组织中的认识。